Overview

Pen Needles Market to value at a CAGR of over 10% during the forecast period from 2022 to 2028.

Pen needles are fairly prevalent in the medical world. It is mainly used for patients diagnosed with diabetes. The market is soaring owing to applications across other industries as well.

Insulin pens are the most efficient and safest way to deliver insulin. With rising consumer awareness, the insulin pen needles are gaining popularity and expanding the market worldwide. The employment of pen needles especially in insulin delivery is increasing as it is highly beneficial and convenient, can be used anywhere due to its simplicity and is self-administered, while maintaining dosage accuracy. The market is expected to grow significantly due to the rising prevalence of diabetes and other chronic diseases. According to the Center for Disease Control (CDC), 11.9% of the U.S. population is suffering from diabetes which is increasing at 0.7% each year, however, 83.2% are diagnosed and the rest are undiagnosed. The major risk associated with diabetes is rising mortality rate. Increasing reimbursements in developing countries also favour the growth of this market.

Based on type, the market is categorized into standard pen needles and safety pen needles. Standard pen needles held major market share due to its daily consumption of big dosages by diabetic patients. The rising number of diabetic population and awareness level regarding the usage of insulin pens are some of the factors supporting the segment growth.

According to needle length, the market is distinguished into 4mm, 5m, 6mm, 8mm, 10mm, and 12mm. The 8mm sized pen needle constituted the largest market share. These types of needles are widely used across all industries and find immense application. Needle length of 4mm is anticipated to witness a robust CAGR over the forecast period owing to its compatible features. Reduced pain and higher accuracy drive the growth of this segment.

On the basis of therapy type, the market has been segmented into insulin, GLP-1, growth hormone and other therapies. The insulin therapy segment dominated the market and is also projected to showcase lucrative growth over the forecast period. This is due to the increasing awareness about self-administration of insulin therapy amongst the type 1 and type 2 diabetes patients.

Market Regional Insights

North America is forecasted to hold major market share in the global pen needles market. Growing number of diabetes cases and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies are factors boosting the market growth.

Prominent players in the market are:

Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG , B. Braun Melsungen AG , HTL-Strefa S.A. , Terumo Corporation, and Owen Mumford, Allison Medical, Inc., UltiMed, Inc., Artsana S.P.A. Arkray, Inc.. Glucorx

Pen Needles Market Segmentation:

By Type

● Standard Pen Needles

● Safety Pen Needles

By Length

● 4mm

● 5mm

● 6mm

● 8mm

● 10mm

● 12mm

By Therapy

● Insulin Therapy

● Glucagon-Like Peptide-1 (GLP-1) Therapy

● Growth Hormone Therapy

● Other Therapies

By Mode of Purchase

● Retail

● Non-Retail

By Region

● Europe

● North America

● Asia-Pacific

● Latin America

● Middle East and Africa

Competitive Landscape

● Tier 1 players- established companies in the market with a major market share

● Tier 2 players

● Emerging players which are growing rapidly

● New Entrants

FutureWise Takeaways

● Growth prospects

● SWOT Analysis

● Key Trends

● Key Data Points Affecting Market Growth

Objectives of the Study:

● To provide an exhaustive analysis on the global pen needles market by type, by length by therapy, by mode of purchase, and by region

● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

● To evaluate and forecast micro-markets and the overall market

● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

● Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com